Demonstrates a sustainable method for synthesizing sulfoximines, suggesting improvements in green chemistry.
Sulfoximines have emerged as versatile scaffolds in modern synthesis, medicinal chemistry, and catalysis due to their tunable electronic and steric properties. In particular, N ‐aroyl sulfoximines are valuable intermediates in amide coupling, CH functionalization, and heterocycle formation. However, conventional synthetic approaches often rely on stoichiometric activating reagents and harsh conditions, generating waste and limiting substrate scope. Herein, we report a sustainable continuous‐flow platform for the Pd‐catalyzed carbonylative N ‐aroylation of sulfoximines employing carbon monoxide (CO) as a C1 source under mild conditions. The system integrates a solid oxide electrolysis cell (SOEC) to generate dry CO from CO 2 on‐demand, enabling a safe, modular, and atom‐economical transformation. The process displayed broad substrate tolerance, accommodating electron‐rich, electron‐poor, and heteroaromatic aryl iodides to furnish N ‐aroyl sulfoximines in 50%–99% isolated yields within 40 min at 80°C and 6 bar. A heterogeneous Pd‐based catalyst, covalently immobilized on Merrifield resin, further enabled efficient flow operation with 96% conversion, facilitating the catalyst recovery. Finally, the adoption of Cyrene, a biomass‐derived solvent, afforded quantitative yields and demonstrated the process compatibility with green solvents. This work establishes a scalable, safe, and sustainable strategy for sulfoximine N ‐aroylation, integrating CO 2 valorization, continuous‐flow technology, and heterogeneous catalysis for modern carbonylation chemistry.
No takes yet. Share an insight, caveat, or question.
Moroni et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: